Hirohisa Tsujinoue

3.1k total citations
50 papers, 2.6k citations indexed

About

Hirohisa Tsujinoue is a scholar working on Molecular Biology, Genetics and Biotechnology. According to data from OpenAlex, Hirohisa Tsujinoue has authored 50 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 17 papers in Genetics and 14 papers in Biotechnology. Recurrent topics in Hirohisa Tsujinoue's work include Virus-based gene therapy research (17 papers), Angiogenesis and VEGF in Cancer (10 papers) and Liver physiology and pathology (9 papers). Hirohisa Tsujinoue is often cited by papers focused on Virus-based gene therapy research (17 papers), Angiogenesis and VEGF in Cancer (10 papers) and Liver physiology and pathology (9 papers). Hirohisa Tsujinoue collaborates with scholars based in Japan, China and Argentina. Hirohisa Tsujinoue's co-authors include Shigeki Kuriyama, Hitoshi Yoshiji, Hiroshi Fukui, Junichi Yoshii, Yasuhide Ikenaka, Ryuichi Noguchi, Toshiya Nakatani, Koji Yanase, Mitsuhiro Kawata and Hiroo Imazu and has published in prestigious journals such as Hepatology, The FASEB Journal and Journal of Hepatology.

In The Last Decade

Hirohisa Tsujinoue

50 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hirohisa Tsujinoue Japan 25 1.1k 931 677 460 455 50 2.6k
Toshiya Nakatani Japan 21 829 0.8× 635 0.7× 452 0.7× 379 0.8× 291 0.6× 51 1.9k
Atsushi Hosui Japan 25 1.1k 1.0× 497 0.5× 721 1.1× 445 1.0× 487 1.1× 52 2.2k
Hideji Nakamura Japan 31 1.6k 1.5× 475 0.5× 389 0.6× 354 0.8× 313 0.7× 101 2.8k
Antonio Mazzocca Italy 30 1.4k 1.3× 768 0.8× 660 1.0× 815 1.8× 691 1.5× 86 3.0k
Shigang Xiong United States 24 1.1k 1.0× 898 1.0× 1.3k 1.9× 241 0.5× 199 0.4× 37 2.9k
Stefania Cannito Italy 29 872 0.8× 1.1k 1.2× 1.0k 1.5× 440 1.0× 582 1.3× 63 2.7k
María J. Perugorria Spain 25 1.1k 1.0× 610 0.7× 557 0.8× 582 1.3× 519 1.1× 52 2.6k
Ryotaro Sakamori Japan 27 790 0.7× 561 0.6× 838 1.2× 556 1.2× 233 0.5× 107 2.4k
Alison Joly United States 18 1.5k 1.4× 405 0.4× 153 0.2× 902 2.0× 432 0.9× 26 2.9k
Hayato Hikita Japan 29 1.7k 1.5× 842 0.9× 1.4k 2.0× 600 1.3× 723 1.6× 133 3.6k

Countries citing papers authored by Hirohisa Tsujinoue

Since Specialization
Citations

This map shows the geographic impact of Hirohisa Tsujinoue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirohisa Tsujinoue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirohisa Tsujinoue more than expected).

Fields of papers citing papers by Hirohisa Tsujinoue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirohisa Tsujinoue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirohisa Tsujinoue. The network helps show where Hirohisa Tsujinoue may publish in the future.

Co-authorship network of co-authors of Hirohisa Tsujinoue

This figure shows the co-authorship network connecting the top 25 collaborators of Hirohisa Tsujinoue. A scholar is included among the top collaborators of Hirohisa Tsujinoue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirohisa Tsujinoue. Hirohisa Tsujinoue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoshiji, Hitoshi, Shigeki Kuriyama, Junichi Yoshii, et al.. (2004). Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in mice. Hepatology. 39(6). 1517–1524. 85 indexed citations
2.
Kuriyama, Shigeki, Hirohisa Tsujinoue, & Hitoshi Yoshiji. (2004). Immune Response to Suicide Gene Therapy. Humana Press eBooks. 90. 353–370. 8 indexed citations
3.
Noguchi, Ryuichi, Hitoshi Yoshiji, Shigeki Kuriyama, et al.. (2003). Combination of interferon-beta and the angiotensin-converting enzyme inhibitor, perindopril, attenuates murine hepatocellular carcinoma development and angiogenesis.. PubMed. 9(16 Pt 1). 6038–45. 57 indexed citations
4.
Yoshiji, Hitoshi, Shigeki Kuriyama, Junichi Yoshii, et al.. (2002). Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma. Hepatology. 35(4). 834–842. 126 indexed citations
5.
Yoshiji, Hitoshi, Shigeki Kuriyama, Junichi Yoshii, et al.. (2002). Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse. Hepatology. 36(4). 850–860. 191 indexed citations
6.
Ishizaka, Shigeaki, Akira Shiroi, Seiji Kanda, et al.. (2002). Development of hepatocytes from embryonic stem cells after transfection with the HNF‐3β gene. The FASEB Journal. 16(11). 1444–1446. 91 indexed citations
7.
Yoshiji, Hitoshi, Junichi Yoshii, Yasuhide Ikenaka, et al.. (2002). Inhibition of renin–angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats. Journal of Hepatology. 37(1). 22–30. 81 indexed citations
8.
Yoshiji, Hitoshi, Shigeki Kuriyama, Junichi Yoshii, et al.. (2001). Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology. 34(4). 745–750. 334 indexed citations
9.
Tsujinoue, Hirohisa, Shigeki Kuriyama, Keiichi Tominaga, et al.. (2001). Intravenous readministration of an adenoviral vector performed long after the initial administration failed to induce re-expression of the original transgene in rats. International Journal of Oncology. 18(3). 575–80. 7 indexed citations
10.
Tsujimoto, Tatsuhiro, Shigeki Kuriyama, Masahide Yoshikawa, et al.. (2000). A CASE OF PEMPHIGUS VULGARIS INVOLVING THE EISOPHAGUS. Acta gastro-enterologica belgica. 42(1). 20–26. 2 indexed citations
11.
Kuriyama, Shigeki, Kentaro Tominaga, Akira Mitoro, et al.. (2000). Immunomodulation with FK506 around the time of intravenous re-administration of an adenoviral vector facilitates gene transfer into primed rat liver. International Journal of Cancer. 85(6). 839–844. 17 indexed citations
12.
Kuriyama, Shigeki, Yosuke Nakatani, Hirohisa Tsujinoue, et al.. (1999). Sonographic estimation of liver tumor development induced by oral administration of thioacetamide in rat.. PubMed. 13(2). 129–34. 7 indexed citations
13.
Yoshiji, Hitoshi, Shigeki Kuriyama, Daniel J. Hicklin, et al.. (1999). KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells. Hepatology. 30(5). 1179–1186. 84 indexed citations
14.
Kuriyama, Shigeki, Masaji Kikukawa, Kazuhiro Masui, et al.. (1999). Cancer gene therapy with HSV‐ tk /GCV system depends on t‐cell‐mediated immune responses and causes apoptotic death of tumor cells In vivo. International Journal of Cancer. 83(3). 374–380. 58 indexed citations
15.
Kuriyama, Shigeki, Manabu Yamazaki, Akira Mitoro, et al.. (1999). Analysis of intrahepatic invasion of hepatocellular carcinoma using fluorescent dye-labeled cells in mice.. PubMed. 18(6A). 4181–8. 16 indexed citations
16.
Cao, Guangwen, Shigeki Kuriyama, Jun Gao, et al.. (1999). Effective and safe gene therapy for colorectal carcinoma using the cytosine deaminase gene directed by the carcinoembryonic antigen promoter. Gene Therapy. 6(1). 83–90. 39 indexed citations
17.
Kuriyama, Shigeki, Masaji Kikukawa, Toshiya Nakatani, et al.. (1999). Transient cyclophosphamide treatment before intraportal readministration of an adenoviral vector can induce re-expression of the original gene construct in rat liver. Gene Therapy. 6(5). 749–757. 12 indexed citations
18.
Kuriyama, Shigeki, Masaharu Yamazaki, Akira Mitoro, et al.. (1999). Hepatocellular carcinoma in an orthotopic mouse model metastasizes intrahepatically in cirrhotic but not in normal liver. International Journal of Cancer. 80(3). 471–476. 30 indexed citations
19.
Kuriyama, Shigeki, Kentaro Tominaga, Masaji Kikukawa, et al.. (1998). Inhibitory effects of human sera on adenovirus-mediated gene transfer into rat liver.. PubMed. 18(4A). 2345–51. 27 indexed citations
20.
Kuriyama, Shigeki, Takemi Sakamoto, Masaji Kikukawa, et al.. (1998). Expression of a retrovirally transduced gene under control of an internal housekeeping gene promoter does not persist due to methylation and is restored partially by 5-azacytidine treatment. Gene Therapy. 5(10). 1299–1305. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshiya Nakatani Breakdown of academic impact, for papers by Atsushi Hosui Breakdown of academic impact, for papers by Hideji Nakamura Breakdown of academic impact, for papers by Antonio Mazzocca Breakdown of academic impact, for papers by Shigang Xiong Breakdown of academic impact, for papers by Stefania Cannito Breakdown of academic impact, for papers by María J. Perugorria Breakdown of academic impact, for papers by Ryotaro Sakamori Breakdown of academic impact, for papers by Alison Joly Breakdown of academic impact, for papers by Hayato Hikita
Rankless by CCL
2026